Export
APA
K. De Boeck, T. Lee, M. Amaral, P. Drevinek, J.S. Elborn, I. Fajac, E. Kerem, J.C. Davies, (2020). Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view. Journal of Cystic Fibrosis, 19, 688-695. ISSN 1569-1993. eISSN . http://dx.doi.org/10.1016/j.jcf.2020.05.012
IEEE
K. De Boeck, T. Lee, M. Amaral, P. Drevinek, J.S. Elborn, I. Fajac, E. Kerem, J.C. Davies, "Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view" in Journal of Cystic Fibrosis, vol. 19, pp. 688-695, 2020.
10.1016/j.jcf.2020.05.012
BIBTEX
@article{49484,
author = {K. De Boeck and T. Lee and M. Amaral and P. Drevinek and J.S. Elborn and I. Fajac and E. Kerem and J.C. Davies},
title = {Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view},
journal = {Journal of Cystic Fibrosis},
year = 2020,
pages = {688-695},
volume = 19
}